These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8083665)

  • 21. Selenium and host defence towards viruses.
    Beck MA
    Proc Nutr Soc; 1999 Aug; 58(3):707-11. PubMed ID: 10604206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The viral genome in experimental murine Coxsackievirus B3 myocarditis: a Northern blotting analysis.
    Okada I; Matsumori A; Kawai C; Yodoi J; Tracy S
    J Mol Cell Cardiol; 1990 Sep; 22(9):999-1008. PubMed ID: 2177795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy.
    Koide H; Kitaura Y; Deguchi H; Ukimura A; Kawamura K; Hirai K
    Jpn Circ J; 1992 Oct; 56(10):1081-93. PubMed ID: 1331557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants.
    Gómez RM; Cui X; Castagnino CG; Berría MI
    Intervirology; 1993; 36(3):153-60. PubMed ID: 8150596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality in mice infected with an amyocarditic coxsackievirus and given a subacute dose of mercuric chloride.
    South PK; Morris VC; Levander OA; Smith AD
    J Toxicol Environ Health A; 2001 Aug; 63(7):511-23. PubMed ID: 11497332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
    Chow LH; Gauntt CJ; McManus BM
    Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidants and viral infections: host immune response and viral pathogenicity.
    Beck MA
    J Am Coll Nutr; 2001 Oct; 20(5 Suppl):384S-388S; discussion 396S-397S. PubMed ID: 11603647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.
    Gauntt CJ; Gomez PT; Duffey PS; Grant JA; Trent DW; Witherspoon SM; Paque RE
    J Virol; 1984 Nov; 52(2):598-605. PubMed ID: 6092681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficient diet evokes nasty heart virus.
    Gauntt C; Tracy S
    Nat Med; 1995 May; 1(5):405-6. PubMed ID: 7585080
    [No Abstract]   [Full Text] [Related]  

  • 30. Benign coxsackievirus damages heart muscle in iron-loaded vitamin E-deficient mice.
    Beck MA; Shi Q; Morris VC; Levander OA
    Free Radic Biol Med; 2005 Jan; 38(1):112-6. PubMed ID: 15589379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.
    Gay RT; Belisle S; Beck MA; Meydani SN
    Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13825-30. PubMed ID: 16950876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
    Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
    Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics of coxsackievirus B3 cardiovirulence.
    Tracy S; Tu Z; Chapman N; Hufnagel G
    Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
    Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
    Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
    Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
    Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successive infection of coxsackievirus B3 and encephalomyocarditis virus: an animal model of chronic myocarditis.
    Okada I; Matsumori A; Tomioka N; Kawai C
    J Pathol; 1992 Jul; 167(3):341-7. PubMed ID: 1325552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
    Zhou L; He X; Gao B; Xiong S
    J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes.
    Lyden DC; Olszewski J; Feran M; Job LP; Huber SA
    Am J Pathol; 1987 Mar; 126(3):432-8. PubMed ID: 3030117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
    Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
    Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.